Chr. Hansen and Novozymes write history as Denmark’s largest merger, scaling up production
date:Dec 20, 2022
and application centers, 23 manufacturing sites, and approximately 2,000 employees in RD. This stands out in the bio-based sector. With 350 million (US$3.72 million) reinvested into RD annually, representing an estimated 10% to 11% of combined sales this also stands out in the bio-based sector.

He explains that the merger will allow the companies to be stronger equipped to transform customer needs into value-added biobased solutions by using existing solutions and leveraging them across combi
4/12 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/03 16:08